BioCorRx (BICX) Income from Non-Controlling Interests (2017 - 2026)
BioCorRx's (BICX) quarterly Income from Non-Controlling Interests came in at -$28665.0 in Q1 2026, down 176.77% year-on-year from $37339.1 in Q1 2025, and up 97.49% quarter-over-quarter from -$1.1 million in Q4 2025.
BioCorRx (BICX) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
BioCorRx has disclosed Income from Non-Controlling Interests across 8 years of filings, most recently posting -$28665.0 for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$28665.0, down 176.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$241140.0 (down 60.42% YoY), and the FY2025 annual result was -$68617.0, up 35.25% from the prior year.
- Income from Non-Controlling Interests came in at -$28665.0 for Q1 2026 at BioCorRx, up from -$1.1 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $1.1 million in Q3 2025 to a low of -$1.1 million in Q4 2025.
- The 3-year median for Income from Non-Controlling Interests is -$22657.5 (2024), against an average of -$48932.8.
- Peak annual rise in Income from Non-Controlling Interests reached 4090.03% in 2025, while the deepest fall reached 764.01% in 2025.
- BioCorRx's Income from Non-Controlling Interests stood at -$148938.0 in 2024, then plunged by 666.92% to -$1.1 million in 2025, then surged by 97.49% to -$28665.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$28665.0 (Q1 2026), -$1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | 237.00 Mn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 204.00 Mn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 77.51 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 53.70 Mn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 88,000.00 |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 10.00 Mn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 88.47 Mn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | -27,000.00 |
| 10 | BioCorRx | - | - | 189,355.00 | -28,665.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,665.00 |
| Dec 31, 2025 | -1.14 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | -143,858.00 |
| Mar 31, 2025 | -10,357.00 |
| Dec 31, 2024 | -148,938.00 |
| Sep 30, 2024 | 25,623.00 |
| Jun 30, 2024 | -16,650.00 |
| Dec 31, 2021 | -1.27 Mn |
| Sep 30, 2021 | -1.36 Mn |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | -1.58 Mn |
| Dec 31, 2020 | -902,571.00 |
| Sep 30, 2020 | -767,661.00 |
| Jun 30, 2020 | -735,437.00 |
| Mar 31, 2020 | -1.07 Mn |
| Dec 31, 2019 | -6.04 Mn |
| Sep 30, 2019 | -1.03 Mn |
| Jun 30, 2019 | -2.04 Mn |
| Mar 31, 2019 | 28.00 |